📰 Il 36 News

Il 36 News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Il 36. Real-time updates on events, politics, business and more.

Spesolimab for Treatment of Generalized Pustular Psoriasis (GPP) Flares

April 19, 2024

Dermatologists Drs Tina Bhutani and Scott Boswell discuss use of spesolimab to treat generalized pustular psoriasis (GPP) flares.

Tina Bhutani J Scott Boswell Kanya Oul Generalized Pustular Psoriasis Inflammatory Disease Gpp Flares

Source: hcplive.com

Use of Biologics in Rare Dermatologic Disorders

May 26, 2023

Experts discuss the use of biologics in the treatment of rare dermatologic disorders.

Identifying Rare Dermatologic Disorders Critical Care Setting Rare Dermatologic Rare Dermatological Disorders Il 36 Il 36 Inhibitors

Source: hcplive.com

Spesolimab meets primary and key secondary endpoint for prevention of generalized pustular psoriasis flares

January 30, 2023

EFFISAYIL™ 2 met its primary and key secondary endpoint, demonstrating that spesolimab, an anti-interleukin-36 receptor antibody, can prevent flares in adolescents and adults with generalized pustular psoriasis (GPP) up to 48 weeks.1,2

Rheinland Pfalz Laura Lessenich Carinne Brouillon European Union Corporate Communications Boehringer Ingelheim

Source: businesswireindia.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Il 36 News Today

Spesolimab for Treatment of Generalized Pustular Psoriasis (GPP) Flares

Use of Biologics in Rare Dermatologic Disorders

Spesolimab meets primary and key secondary endpoint for prevention of generalized pustular psoriasis flares

Explore More Categories